Molecule intelOpportunity: Moderate0

Piracetam

26 brands · 20 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
47
Market saturation
52
Price room
100
Regulatory risk
50
26
brands
20
companies
Rs 465.5
median price
8
price points
8.69x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 97
MedianRs 465.5
Most expensiveRs 843.33
Spread8.69×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 8.69x across 8 trusted points (Rs 97.0-843.33). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Piracetam — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2021-11-29
Drug Product Recall: M/S. Gsk Pakistan Limited, Karachi issued voluntary recall of Nootrop

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(48) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

20 canonical companies and 26 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 8.69x across 8 trusted points (Rs 97.0-843.33). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2021-11-29 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.